Journal
TISSUE ENGINEERING PART A
Volume 17, Issue 19-20, Pages 2497-2509Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/ten.tea.2010.0705
Keywords
-
Categories
Funding
- NIH/NIDCR [R21 DE0177711, RO1 DE01607]
- UC [07.10677]
- California Institute for Regenerative Medicine [TG2-01169]
- T32 grant [5T32DE007296-14]
- MRC [G1000816] Funding Source: UKRI
- Medical Research Council [G1000816] Funding Source: researchfish
Ask authors/readers for more resources
The search for novel sources of stem cells other than bone marrow mesenchymal stem cells (MSCs) for bone regeneration and repair has been a critical endeavor. We previously established an effective protocol to homogeneously purify human pericytes from multiple fetal and adult tissues, including adipose, bone marrow, skeletal muscle, and pancreas, and identified pericytes as a primitive origin of human MSCs. In the present study, we further characterized the osteogenic potential of purified human pericytes combined with a novel osteoinductive growth factor, Nell-1. Purified pericytes grown on either standard culture ware or human cancellous bone chip (hCBC) scaffolds exhibited robust osteogenic differentiation in vitro. Using a nude mouse muscle pouch model, pericytes formed significant new bone in vivo as compared to scaffold alone (hCBC). Moreover, Nell-1 significantly increased pericyte osteogenic differentiation, both in vitro and in vivo. Interestingly, Nell-1 significantly induced pericyte proliferation and was observed to have pro-angiogenic effects, both in vitro and in vivo. These studies suggest that pericytes are a potential new cell source for future efforts in skeletal regenerative medicine, and that Nell-1 is a candidate growth factor able to induce pericyte osteogenic differentiation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available